• Careers
  • Contact Us

Common Painkillers Could Increase Cancer Survival Rates by a Third

on Tuesday, 12 March 2019.

Researchers at the University of California, San Francisco have found that the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and aspirin, boosted survival rates in head and neck cancer sufferers from 25% to 78%.

The increase in survival rate was linked to the cancer containing a specific mutated gene known as PIK3CA, which is found in approximately one third of head and neck cancers.

It is hoped that despite the study focusing on head and neck cancer patients, that any cancer sufferer whose cancer contains the PIK3CA mutation gene could gain a more favourable outcome through the use of NSAIDs.


For more information, please contact Laura Barrell in our Pharmaceuticals & Life Sciences team on 01923 919 313.

Leave a comment

You are commenting as guest.